Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GILTERITINIB vs GLATIRAMER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GILTERITINIB vs GLATIRAMER: Safety Overview

Metric GILTERITINIB GLATIRAMER
Total FAERS Reports 3,672 46,357
Deaths Reported 1,014 696
Death Rate 27.6% 1.5%
Hospitalizations 1,407 5,831
Average Patient Age 60.8 yrs 48.4 yrs
% Female Patients 48.5% 81.0%
FDA Approval Date Nov 28, 2018 Apr 16, 2015
Manufacturer Astellas Pharma US, Inc. Zydus Pharmaceuticals USA Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Discontinued